Cite
A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance
MLA
Mudhar, Hardeep Singh, et al. “A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance.” Laboratory Investigation, vol. 104, no. 1, Jan. 2024. EBSCOhost, https://doi.org/10.1016/j.labinv.2023.100281.
APA
Mudhar, H. S., Krishna, Y., Cross, S., Auw-Haedrich, C., Barnhill, R., Cherepanoff, S., Eagle, R., Farmer, J., Folberg, R., Grossniklaus, H., Herwig-Carl, M. C., Hyrcza, M., Lassalle, S., Loeffler, K. U., Moulin, A., Milman, T., Verdijk, R. M., Heegaard, S., & Coupland, S. E. (2024). A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance. Laboratory Investigation, 104(1). https://doi.org/10.1016/j.labinv.2023.100281
Chicago
Mudhar, Hardeep Singh, Yamini Krishna, Simon Cross, Claudia Auw-Haedrich, Raymond Barnhill, Svetlana Cherepanoff, Ralph Eagle, et al. 2024. “A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance.” Laboratory Investigation 104 (1). doi:10.1016/j.labinv.2023.100281.